Pomerantz Law Firm Reminds Shareholders of China Sky One Medical, Inc. of Upcoming Deadline -- CSKI
07 4월 2012 - 2:28AM
Shareholders of China Sky One Medical, Inc. ("China Sky" or the
"Company) (Nasdaq:CSKI) are reminded of the securities class action
lawsuit filed against China Sky and certain of its officers. The
class action (12 Civ. 1418) in the United States District Court,
Southern District of New York, is on behalf of all persons who
purchased China Sky securities between April 16, 2009 and February
14, 2012, inclusive (the "Class Period"). This class action is
brought under the Sections 10(b) and 20(a) of the Securities
Exchange Act of 1934 against the Company and certain of its top
officials.
If you are a shareholder who purchased China Sky securities
during the Class Period, you have until April 24, 2012 to ask the
Court to appoint you as Lead Plaintiff for the class. A copy of the
complaint can be obtained at www.pomerantzlaw.com. To discuss this
action, contact Rachelle R. Boyle at rrboyle@pomlaw.com or
888.476.6529 (or 888.4-POMLAW), toll free, x350. Those who inquire
by e-mail are encouraged to include their mailing address and
telephone number.
China Sky manufactures pharmaceutical and medicinal products and
diagnostics kits. The Complaint alleges that throughout the Class
Period, China Sky made false and/or misleading statements and/or
failed to disclose that: (1) the Company improperly inflated
earnings; (2) the Company's gross margins were inflated; (3) the
Company lacked adequate internal and financial controls; and (4) as
a result of the foregoing, the Company's statements were materially
false and misleading at all relevant times.
On February 15, 2012, the Company disclosed the resignation of
26 middle-management level employees, nine of whom worked in the
Company's accounting department. On that same day, NASDAQ announced
it had halted trading in the stock until it received adequate
"additional information requested" from the Company. On these
revelations, China Sky's shares declined $0.43 per share or 28%, to
close at $1.10 on February 15, 2012.
The Pomerantz Firm, with offices in New York, Chicago, and
Washington, D.C., is acknowledged as one of the premier firms in
the areas of corporate, securities, and antitrust class litigation.
Founded by the late Abraham L. Pomerantz, known as the dean of the
class action bar, the Pomerantz Firm pioneered the field of
securities class actions. Today, more than 70 years later, the
Pomerantz Firm continues in the tradition he established, fighting
for the rights of the victims of securities fraud, breaches of
fiduciary duty, and corporate misconduct. The Firm has recovered
numerous multimillion-dollar damages awards on behalf of class
members. See www.pomerantzlaw.com.
CONTACT: Rachelle R. Boyle
Pomerantz Haudek Grossman & Gross LLP
rrboyle@pomlaw.com
China Sky One Medical, Inc. (MM) (NASDAQ:CSKI)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
China Sky One Medical, Inc. (MM) (NASDAQ:CSKI)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024